Development of a short‐term reproductive endocrine bioassay using steroid hormone and vitellogenin end points in the estuarine mummichog (Fundulus heteroclitus)
Journal Articles
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
AbstractWe have developed a short‐term gonadal recrudescence test with the estuarine mummichog (Fundulus heteroclitus) and determined endocrine end points sensitive to a strong estrogen agonist (ethynylestradiol; EE2) and an antiestrogen (ZM 189,154; ZM) at concentrations of 0 to 1,000 ng/L in three separate experiments. A protocol was developed to ensure a year‐round supply of recrudescing fish. A protocol for determining steroid production (testosterone and 11‐ketotestosterone [11‐KT] in incubated testes tissue and testosterone and 17‐estradiol [E2] in incubated prematurational follicles) was optimized. Recrudescing fish (males, gonadosomatic index = 2%; females = 10%) were exposed to graded doses of EE2 or ZM for 7 to 15 d using a static daily‐renewal protocol. At high EE2 (>250 ng/L), the effect on males was depression of androgen steroidogenesis and plasma steroid levels. In females, high EE2 depressed gonadal production and circulating E2 levels; however, EE2 concentrations <100 ng/L caused increased gonadal production and plasma E2. Low ZM (<100 ng/L) had little effect on male and female fish, while higher concentrations (>250 ng/L) increased E2 and 11‐KT production while decreasing plasma 11‐KT and E2 (1,000 ng/L only). Male and female plasma vitellogenin responded in a concentration‐dependent fashion to EE2 with no effect by ZM. The low observable effect concentrations for the endocrine parameters were 1 ng/L for EE2 and 250 ng/L for ZM. The bioassay and results encompassing the environmentally relevant exposure range (1–100 ng/L) will be useful for assessing effects of endocrine‐active contaminants in estuarine environments.
